These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1184 related articles for article (PubMed ID: 2501395)

  • 1. Analysis of initial melanogenesis including tyrosinase transfer and melanosome differentiation through interrupted melanization by glutathione.
    Imokawa G
    J Invest Dermatol; 1989 Jul; 93(1):100-7. PubMed ID: 2501395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of carbohydrate properties essential for melanogenesis in tyrosinases of cultured malignant melanoma cells by differential carbohydrate processing inhibition.
    Imokawa G
    J Invest Dermatol; 1990 Jul; 95(1):39-49. PubMed ID: 2114451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional analysis of tyrosinase isozymes of cultured malignant melanoma cells during the recovery period following interrupted melanogenesis induced by glycosylation inhibitors.
    Imokawa G; Mishima Y
    J Invest Dermatol; 1984 Sep; 83(3):196-201. PubMed ID: 6432920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of glycoproteins in the initiation of melanogenesis: an electron microscopic study of B-16 melanoma cells after release from inhibition of glycosylation.
    Imokawa G; Mishima Y
    J Invest Dermatol; 1986 Sep; 87(3):319-25. PubMed ID: 3734483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Origin of melanosome structures and cytochemical localizations of tyrosinase activity in differentiating epidermal melanocytes of newborn mouse skin.
    Hirobe T
    J Exp Zool; 1982 Dec; 224(3):355-63. PubMed ID: 6818322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of pigmentation in mouse melanoma cells by 5-bromodeoxyuridine: effects on tyrosinase activity and melanosome formation.
    Wrathall JR; Oliver C; Silagi S; Essner E
    J Cell Biol; 1973 May; 57(2):406-23. PubMed ID: 4633171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and biological control of melanogenesis through tyrosinase genes and intrinsic and extrinsic regulatory factors.
    Mishima Y
    Pigment Cell Res; 1994 Dec; 7(6):376-87. PubMed ID: 7761345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analyses of mixed melanogenesis in tyrosinase cDNA-transfected human amelanotic melanoma cells.
    Ando O; Mishima Y; Hanada S; Suemoto Y; Atobe J; Kurimoto M
    J Invest Dermatol; 1993 Dec; 101(6):864-70. PubMed ID: 8245515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of sulfhydryl compounds in mammalian melanogenesis: the effect of cysteine and glutathione upon tyrosinase and the intermediates of the pathway.
    Jara JR; Aroca P; Solano F; Martinez JH; Lozano JA
    Biochim Biophys Acta; 1988 Nov; 967(2):296-303. PubMed ID: 2903772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of melanogenic properties in tyrosinases induced by glucosylation inhibitors within malignant melanoma cells.
    Imokawa G; Mishima Y
    Cancer Res; 1982 May; 42(5):1994-2002. PubMed ID: 6802485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective aberration and pigment loss in melanosomes of malignant melanoma cells in vitro by glycosylation inhibitors: premelanosomes as glycoprotein.
    Mishima Y; Imokawa G
    J Invest Dermatol; 1983 Aug; 81(2):106-14. PubMed ID: 6409969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced glutathione disrupts the intracellular trafficking of tyrosinase and tyrosinase-related protein-1 but not dopachrome tautomerase and Pmel17 to melanosomes, which results in the attenuation of melanization.
    Nakajima H; Nagata T; Koga S; Imokawa G
    Arch Dermatol Res; 2014 Jan; 306(1):37-49. PubMed ID: 23764898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of tyrosinases as asparagin-linked oligosaccharides by concanavalin A lectin chromatography: appearance of new segment of tyrosinases in melanoma cells following interrupted melanogenesis induced by glycosylation inhibitors.
    Imokawa G; Mishima Y
    J Invest Dermatol; 1985 Aug; 85(2):165-8. PubMed ID: 3926905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoelectron microscopic localization of tyrosinase in the mouse melanocyte.
    Yamamoto H; Takeuchi T
    J Histochem Cytochem; 1981 Aug; 29(8):953-8. PubMed ID: 6792273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing of PMEL attenuates melanization via activating lysosomes and degradation of tyrosinase by lysosomes.
    Sun L; Hu L; Zhang P; Li H; Sun J; Wang H; Xie X; Hu J
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2536-2542. PubMed ID: 30208522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and biochemical characterization of tyrosinase-rich GERL and coated vesicle in melanin synthesizing cells.
    Imokawa G; Mishima Y
    Br J Dermatol; 1981 Feb; 104(2):169-78. PubMed ID: 6783060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-tyrosine, L-dopa, and tyrosinase as positive regulators of the subcellular apparatus of melanogenesis in Bomirski Ab amelanotic melanoma cells.
    Slominski A; Moellmann G; Kuklinska E
    Pigment Cell Res; 1989; 2(2):109-16. PubMed ID: 2497448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A polymethoxyflavone mixture extracted from orange peels, mainly containing nobiletin, 3,3',4',5,6,7,8-heptamethoxyflavone and tangeretin, suppresses melanogenesis through the acidification of cell organelles, including melanosomes.
    Yoshizaki N; Hashizume R; Masaki H
    J Dermatol Sci; 2017 Oct; 88(1):78-84. PubMed ID: 28629701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inulavosin, a melanogenesis inhibitor, leads to mistargeting of tyrosinase to lysosomes and accelerates its degradation.
    Fujita H; Motokawa T; Katagiri T; Yokota S; Yamamoto A; Himeno M; Tanaka Y
    J Invest Dermatol; 2009 Jun; 129(6):1489-99. PubMed ID: 19110539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MSH inhibits growth in a line of amelanotic hamster melanoma cells and induces increases in cyclic AMP levels and tyrosinase activity without inducing melanogenesis.
    Slominski A; Moellmann G; Kuklinska E
    J Cell Sci; 1989 Apr; 92 ( Pt 4)():551-9. PubMed ID: 2557357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.